Advancements in Multiple Myeloma Treatment with BELLA

This chapter discusses the novel antibody drug conjugate BELLA, emphasizing its mechanisms, recent study results, and potential benefits in treating multiple myeloma, especially in high-risk patients. It highlights the effectiveness of combination therapies and innovative dosing strategies while addressing associated adverse events.

Transcript

Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.